News Focus
News Focus
Followers 480
Posts 61846
Boards Moderated 15
Alias Born 09/20/2001

Re: None

Tuesday, 03/26/2019 10:28:47 PM

Tuesday, March 26, 2019 10:28:47 PM

Post# of 21574
It's really amazing how many people are fooled by Anavex and Missling. They're presenting to another professional group, the American Society for Experimental Neurotherapeutcs.


Annual Meeting Keynote
ASENT is pleased to announce that Dr. Robert Temple, MD, CDER’s Deputy Center Director for Clinical Science and Acting Deputy Director of the Office of Drug Evaluation, will deliver a keynote address at the ASENT 2019 Annual Meeting. Dr. Temple will share his knowledge on trial design, new design parameters, outcomes and new approaches using genetics and molecular biology to enrich the clinical studies.


Dr. Temple’s keynote will take place on Tuesday, March 26, 2019 at 8:00 am, at the Bethesda North Marriott in Rockville, MD. We are pleased to welcome Dr. Temple and hope you will have the opportunity to hear this important presentation.


https://www.asent.org/?

Poster:

Page 9
Day 2:Wednesday, March 27 3:30-5pm


The ASENT Pipeline Sessions are brief podium presentations. These presentations are derived from the abstract submissions and vetted by our abstract review committee to ensure the highest caliber and most novel research.



Page 10


3:48 - 4:03 PM
Salons A-B
Longitudinal 148-Week Extension Study Of Anavex®2-73 For The Treatment Of Alzheimer’s
Disease Demonstrates Maintained Activities Of Daily Living Score (ADCS-ADL) And Reduced
Cognitive Decline (MMSE) For Patient Cohort On Higher Drug Concentration And Confirms
Role Of Precision Medicine Patient Selection Biomarkers
Walter E. Kaufmann, MD, Anavex Life Sciences




Page 16 - Posters


5 LONGITUDINAL 148-WEEK EXTENSION STUDY OF ANAVEX®2-73 FOR THE TREATMENT OF
ALZHEIMER’S DISEASE DEMONSTRATES MAINTAINED ACTIVITIES OF DAILY LIVING SCORE (ADCSADL) AND REDUCED COGNITIVE DECLINE (MMSE) FOR PATIENT COHORT ON HIGHER DRUG
CONCENTRATION AND CONFIRMS ROLE OF PRECISION MEDICINE PATIENT SELECTION
BIOMARKERS
Harald Hampel, Mohammad Afshar, Frédéric Parmentier, Coralie Williams, Adrien Etcheto, Federico Goodsaid, Christopher U Missling




https://cdn.ymaws.com/www.asent.org/resource/resmgr/docs/19_annual_meeting/onsite_program_19_v2a.pdf



In Peace, In War

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TAOX News